X
KEY PRODUCTS KEY SERVICES
https://www.chemanager-online.com/en/news/axplora-aims-make-pharmaceutical-supply-chains-more-stable
https://www.cphi-online.com/axplora-the-partner-of-choice-for-complex-apis-news119244.html
https://www.axplora.com/farmabios-novasep-and-pharmazell-are-now-axplora/
https://www.cphi-online.com/farmabios-novasep-pharmazell-are-now-one-group-news118870.html
https://www.novasep.com/company/media-events/press-release/novasep-pharmazell-invests-7.3-millions-euros-to-increase-api-production-capacity-at-mourenx-site.html
https://pharmazell-group.com/blog/2022/04/07/pharmazell-and-novasep-announce-the-creation-of-a-leading-cdmo-and-api-manufacturer/
https://www.fitchratings.com/research/corporate-finance/fitch-affirms-european-medco-development-3-sarl-idr-at-b-on-novasep-acquisition-25-10-2021
https://farmabios.com/de/2021/10/06/us-fda-approval-for-teriflunomide-it-2-2/
https://www.prnewswire.com/news-releases/breckenridge-announces-approval-of-its-anda-for-teriflunomide-tablets-generic-for-aubagio-301387953.html
https://farmabios.com/2021/09/16/pharmazell-and-novasep-enter-into-exclusive-negotiations-in-new-drive-to-create-a-technology-driven-leader-for-complex-small-molecules-and-adcs-of-global-scale/
Market Place
Share 
